{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:58:47Z","timestamp":1767664727780},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2022-7-6","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T10:02:17Z","timestamp":1670407337000},"page":"1-14","source":"Crossref","is-referenced-by-count":1,"title":["Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with \u03b2-thalassaemia\/HbE"],"prefix":"10.7573","volume":"11","author":[{"given":"Ngan Thi","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranee","family":"Sutcharitchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindaporn","family":"Janprasit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ponlapat","family":"Rojnuckarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noppawan Phumala","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rataya","family":"Luechapudiporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2022,12,12]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2022\/12\/dic.2022-7-6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T10:42:36Z","timestamp":1670409756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/deferiprone-an-iron-chelator-alleviates-plateletbrhyperactivity-in-patients-with-\u03b2-thalassaemia-hb-e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2022-7-6","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]}}}